
Transparent Pricing That Delivers Value CURA™’s CPCC Model Explained
In the MedTech industry, software pricing has long been a challenge. Many solutions are tied to complex licensing models, per-user fees, or fixed annual contracts that demand large upfront commitments. Yet these costs are often disconnected from actual performance. Teams may pay thousands for access to tools that never deliver the efficiency, accuracy, or compliance improvements they were promised. The result is an industry weighed down by unpredictable costs and limited flexibility.
CURA™ introduces a different, more transparent approach.
Instead of charging for access, CURA™ uses a performance-based model built around the Cost Per Closed Complaint (CPCC). This means payment occurs only when CURA™ automatically closes a complaint using its intelligent automation logic. The fee is a small fraction of the CPCC and applies solely to cases that are fully processed by the platform from intake to resolution.
This approach links pricing directly to outcomes rather than usage. Organizations are not billed for user accounts, licenses, or general access. Instead, they pay for results that demonstrate tangible value.
A Transparent and Predictable Model
The CPCC model eliminates the traditional uncertainties of enterprise software costs. There are no setup charges, hidden fees, or feature-based pricing tiers. Every customer receives full access to all CURA™ modules — including complaint handling, PMS trending, PSUR generation, adverse event reporting, and continuous improvement — without restriction.
This structure allows organizations to plan budgets with confidence. Costs correspond to activity levels and operational performance rather than arbitrary license limits. For smaller teams, expenses remain low during early implementation phases. As activity grows, the system scales accordingly, ensuring that every cost is aligned with measurable output.
Aligning Price with Performance
At its core, the CPCC model is designed to create fairness and accountability. Each closed complaint represents a process that has been fully automated, documented, and verified by the system. Linking cost directly to these successful outcomes ensures that value creation drives investment decisions.
Unlike traditional pricing, where fees are fixed regardless of results, this model establishes a clear relationship between operational improvement and financial commitment. It rewards efficiency, continuous improvement, and data-driven decision-making. For MedTech organizations focused on compliance and performance, this alignment is both practical and strategic.
Scalable for Every Stage of Growth
CURA™ is designed to evolve with the needs of any organization. Whether a company is introducing its first medical device or expanding to multiple global markets, the CPCC model scales naturally. There is no need to negotiate new user tiers or feature bundles. As workload and automation levels increase, costs grow proportionally.
This scalability ensures that organizations of any size can benefit from advanced lifecycle management tools without the financial risk associated with large-scale software commitments. It also promotes a culture of continuous adoption, since new teams or product lines can be added without impacting existing pricing structures.
Efficiency, Compliance, and Measurable Value
The impact of CURA™’s model extends beyond cost control. By connecting pricing to performance, it encourages a focus on measurable results. The platform streamlines complaint handling, automates post-market processes, and integrates compliance requirements into every workflow. The outcome is a more consistent, data-driven operation that supports faster decision-making and stronger regulatory alignment.
Every feature in CURA™ is designed to minimize manual effort, reduce redundancy, and improve traceability. QA and RA teams can dedicate more time to strategic initiatives while maintaining full oversight of quality and compliance indicators. The CPCC model ensures that these improvements translate directly into business value rather than additional overhead.
A Smarter Way to Invest
CURA™’s performance-based pricing reflects a simple principle: software should be paid for only when it delivers measurable outcomes. This approach eliminates upfront risk, avoids unnecessary complexity, and replaces traditional contracts with a transparent framework built on trust and accountability.
By aligning technology costs with operational success, CURA™ redefines what value-based pricing means for the MedTech sector. It is not just a financial model but a reflection of how innovation, automation, and measurable results can work together to create sustainable efficiency across the entire product lifecycle.
Explore CURA™ pricing and discover how performance-based value can transform lifecycle management.
